Loss of IRF8 inhibits the growth of acute myeloid leukemia cells
Authors:
- 23 March 2023
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (5) , 1063-1072
Abstract
The transcription factor interferon regulatory factor 8 (IRF8), as a member of the IRF family, is essential for myeloid cell differentiation. However, the precise role of IRF8 in the pathogenesis of acute myeloid leukemia (AML) remains unknown. By using multivariate analysis, we discovered that high IRF8 expression was an independent poor predictor of overall survival (OS) in AML patients from our clinical follow-up study. The proliferation of three AML cell lines was significantly inhibited by shRNA-mediated knockdown of IRF8, owing to cell cycle S-phase arrest. Furthermore, we demonstrated that knocking down IRF8 could suppress the expression of CyclinA and CyclinB1, resulting in a shift in cell cycle distribution. Loss of IRF8 in AML cells decreased the expression of STAT3 and phosphor-STAT3 (pSTAT3), which are key factors in JAK/STAT signal pathway and are important for AML progression. Using a xenograft mouse model, we discovered the antiproliferative effect of losing IRF8 in vivo. In conclusion, this study found that IRF8 may play a prognostic factor and therapeutic target in AML.Keywords
Funding Information
- Zhejiang Province Traditional Chinese medicine science and technology project (2023ZL685)
- Natural Science Foundation of Ningbo Municipality (20221JCGY010278)
- NINGBO Medical & Health Leading Academic Discipline Project (2022-S05)
This publication has 39 references indexed in Scilit:
- Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axisJournal of Clinical Investigation, 2013
- The Prognostic Significance of IRF8 Transcripts in Adult Patients with Acute Myeloid LeukemiaPLOS ONE, 2013
- Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiationBlood, 2013
- Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitorBlood, 2011
- Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide TherapyJournal of Clinical Oncology, 2009
- Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myelomaExperimental Hematology, 2008
- IRF8 regulates B-cell lineage specification, commitment, and differentiationBlood, 2008
- DNA Replication Stalling Attenuates Tyrosine Kinase Signaling to Suppress S Phase ProgressionCancer Cell, 2008
- Epigenetic disruption of interferon-γ response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomasOncogene, 2008
- Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications, 2007